Inspire Medical Systems INSP
$55.10 −$1.18 (-2.10%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $55.10 0.00%
Open$56.24
Prev close$56.28
Day range$54.90 – $56.93
Volume552.3K
Market cap$1.60B
P/E (TTM)16.4
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$206.70M-7.9% YoY
Operating profit-$28.72M-397.8% YoY
Net profit-$24.39M-345.6% YoY
Diluted EPS-$0.84-347.1% YoY
Free cash flow$38.88M-33.1% YoY
Operating cash flow$46.43M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin86.2%
Operating margin1.8%
Net margin11.4%
Return on equity13.5%
Return on assets11.4%
Return on invested capital11.8%
Current ratio6.45
Liabilities / assets13.2%
Cash & investments$327.97M
Total debt$28.61M
Net cash (debt)$299.36M
Free cash flow / sales11.1%
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $206.70M | $200.58M | $204.58M | $911.98M | $269.08M |
| Total Operating Revenue | $206.70M | $200.58M | $204.58M | $911.98M | $269.08M |
| Cost of Revenue | $28.84M | $29.12M | $27.67M | $133.23M | $36.07M |
| Gross Profit | $177.86M | $171.46M | $176.91M | $778.76M | $233.01M |
| Operating Expense | $206.57M | $171.97M | $178.03M | $727.80M | $186.90M |
| Selling and Admin Expenses | $184.40M | $147.28M | $152.20M | $624.64M | $161.95M |
| Research & Development | $22.18M | $24.70M | $25.83M | $103.17M | $24.94M |
| Operating Profit | -$28.72M | -$514,000.00 | -$1.12M | $50.95M | $46.11M |
| Net Non-Operating Interest Income (Expense) | $3.90M | $3.74M | $3.74M | $17.40M | $3.88M |
| Non-Operating Interest Income | $3.90M | $3.74M | $3.74M | $17.54M | $4.02M |
| Other Income (Expense) | -$191,000.00 | -$110,000.00 | -$226,000.00 | -$2.66M | $330,000.00 |
| Other Non-Operating Income (Expenses) | -$191,000.00 | -$110,000.00 | -$226,000.00 | -$2.66M | $330,000.00 |
| Pretax Profit | -$25.01M | $3.12M | $2.40M | $65.70M | $50.32M |
| Tax | -$616,000.00 | $2.80M | $13.69M | -$79.73M | -$85.77M |
| Net Profit | -$24.39M | $314,000.00 | -$11.29M | $145.42M | $136.09M |
| Profit from Continuing Operations | -$24.39M | $314,000.00 | -$11.29M | $145.42M | $136.09M |
| Net Income to Parent Company | -$24.39M | $314,000.00 | -$11.29M | $145.42M | $136.09M |
| Net Income to Common Stockholders | -$24.39M | $314,000.00 | -$11.29M | $145.42M | $136.09M |
| Basic EPS | -$0.84 | $0.01 | -$0.39 | $4.95 | $4.70 |
| Diluted EPS | -$0.84 | $0.01 | -$0.39 | $4.89 | $4.66 |
| Non-Operating Interest Expense | – | – | – | $137,000.00 | $122,000.00 |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $953.03M | $925.99M | $911.38M | $907.32M | $907.32M |
| Total Current Assets | $627.63M | $608.67M | $566.82M | $583.65M | $583.65M |
| Cash and Cash Equivalents & Short-Term Investments | $327.97M | $320.68M | $283.83M | $308.27M | $308.27M |
| -Cash and Cash Equivalents | $190.80M | $127.76M | $98.93M | $104.81M | $104.81M |
| -Short Term Investments | $137.17M | $192.92M | $184.90M | $203.46M | $203.46M |
| Receivables | $104.71M | $103.34M | $105.09M | $119.69M | $119.69M |
| -Accounts Receivable | $104.71M | $103.34M | $105.09M | $119.69M | $119.69M |
| Inventory | $178.96M | $170.45M | $166.24M | $145.29M | $145.29M |
| Other Current Assets | $15.99M | $14.20M | $11.66M | $10.40M | $10.40M |
| Total Non-Current Assets | $325.41M | $317.32M | $344.56M | $323.67M | $323.67M |
| Net PPE | $107.76M | $126.93M | $123.76M | $121.40M | $121.40M |
| -Gross PPE | $107.76M | $126.93M | $123.76M | $147.05M | $147.05M |
| Investments and Advances | $125.13M | $94.48M | $115.88M | $96.33M | $96.33M |
| -Available for Sale Securities | $125.13M | $94.48M | $115.88M | $96.33M | $96.33M |
| Non-Current Deferred Assets | $74.20M | $77.58M | $87.67M | $88.67M | $88.67M |
| Other Non-Current Assets | $18.33M | $18.33M | $17.25M | $17.26M | $17.26M |
| Total Liabilities | $126.08M | $100.41M | $119.04M | $126.16M | $126.16M |
| Total Current Liabilities | $97.34M | $71.18M | $89.42M | $96.06M | $96.06M |
| Payables | $38.07M | $27.10M | $41.85M | $39.02M | $39.02M |
| -Accounts Payable | $38.07M | $27.10M | $41.85M | $36.57M | $36.57M |
| Current Accrued Expenses | $59.27M | $44.08M | $47.57M | $54.88M | $54.88M |
| Total Non-Current Liabilities | $28.75M | $29.23M | $29.62M | $30.10M | $30.10M |
| Long Term Debt and Capital Lease Obligation | $28.61M | $29.09M | $29.55M | $30.00M | $30.00M |
| -Long Term Capital Lease Obligation | $28.61M | $29.09M | $29.55M | $30.00M | $30.00M |
| Other Non-Current Liabilities | $135,000.00 | $136,000.00 | $66,000.00 | $104,000.00 | $104,000.00 |
| Total Equity | $826.95M | $825.58M | $792.34M | $781.16M | $781.16M |
| Stockholders' Equity | $826.95M | $825.58M | $792.34M | $781.16M | $781.16M |
| Capital Stock | $29,000.00 | $29,000.00 | $29,000.00 | $29,000.00 | $29,000.00 |
| -Common Stock | $29,000.00 | $29,000.00 | $29,000.00 | $29,000.00 | $29,000.00 |
| -Preferred Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Additional Paid-In Capital | $1.01B | $983.67M | $950.45M | $927.16M | $927.16M |
| Retained Earnings | -$181.87M | -$157.47M | -$157.79M | -$146.49M | -$146.49M |
| Gains/Losses Not Affecting Retained Earnings | -$1.45M | -$645,000.00 | -$352,000.00 | $464,000.00 | $464,000.00 |
| -Accumulated Depreciation | – | – | – | -$25.65M | -$25.65M |
| -Total Tax Payable | – | – | – | $2.45M | $2.45M |
| Short-Term Debt and Capital Lease Obligation | – | – | – | $2.16M | $2.16M |
| -Current Capital Lease Obligation | – | – | – | $2.16M | $2.16M |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | $46.43M | $23.23M | $12.85M | $116.98M | $52.47M |
| Net cash flow from continuing operations | $46.43M | $23.23M | $12.85M | $116.98M | $52.47M |
| Net Income from Continuing Operations | -$24.39M | $314,000.00 | -$11.29M | $145.42M | $136.09M |
| Depreciation & Depletion & Amortization | $5.14M | $4.60M | $5.11M | $13.96M | $3.82M |
| Deferred Tax | $3.39M | $10.15M | $1.01M | -$88.75M | -$88.75M |
| Other Non-Cash Items | $349,000.00 | $193,000.00 | $548,000.00 | $2.11M | $325,000.00 |
| Change in Working Capital | $14.34M | -$22.83M | -$13.11M | -$87.38M | -$26.85M |
| -Change in Receivables | -$1.11M | $1.93M | $14.29M | -$26.23M | -$11.63M |
| -Change in Inventory | -$8.51M | -$4.22M | -$20.94M | -$65.18M | -$3.52M |
| -Change in Prepaid Assets | -$1.79M | -$2.81M | -$1.26M | $1.65M | $3.76M |
| -Change in Payables and Accrued Expense | $25.75M | -$17.74M | -$5.19M | $2.38M | -$15.47M |
| Net cash flow from investing | $17.05M | $3.55M | -$11.25M | $21.45M | -$11.92M |
| Net Cash Flow from Continuing Investing Activities | $17.05M | $3.55M | -$11.25M | $21.45M | -$11.92M |
| Net Investment Purchase and Sale | $24.59M | $12.71M | -$1.52M | $59.95M | -$1.26M |
| Financing Cash Flow | -$436,000.00 | $1.91M | -$7.48M | -$183.45M | -$48.31M |
| Net Cash Flow from Continuing Financing Activities | -$436,000.00 | $1.91M | -$7.48M | -$183.45M | -$48.31M |
| Net Common Stock Issuance | $0.00 | $0.00 | $0.00 | -$175.02M | -$50.01M |
| Proceeds from Stock Option Exercised | $313,000.00 | $2.60M | $109,000.00 | $14.61M | $2.40M |
| Net Other Financing Charges | -$749,000.00 | -$685,000.00 | -$7.59M | -$23.04M | -$694,000.00 |
| Ending Cash Balance | $190.80M | $127.76M | $98.93M | $104.81M | $104.81M |
| Net Change in Cash | $63.04M | $28.69M | -$5.88M | -$45.03M | -$7.76M |
| Beginning Cash Balance | $127.76M | $98.93M | $104.81M | $150.15M | $112.85M |
| Effect of Exchange Rate Changes | $4,000.00 | $142,000.00 | $1,000.00 | -$310,000.00 | -$275,000.00 |
| Free Cash Flow | $38.88M | $14.07M | $3.12M | $78.48M | $41.81M |
| Capital Expenditure | – | -$9.16M | -$9.73M | – | – |
| Net PPE Purchase and Sale | – | – | – | -$38.50M | -$10.66M |
No comments yet — be the first to weigh in on INSP.
Sign in to join the discussion.